By G HossainPosted on April 30, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Eli Lilly’s $19.8 billion revenue for the first quarter could have been higher if not for declining prices for key medicines like Zepbound, Mounjaro and Taltz. Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth Post navigation AstraZeneca prunes asthma, rare disease pipeline, cultivates cancer portfolioAvalyn beats expectations with $300M debut